TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹905 Cr | ₹186 Cr | ₹-134 Cr | ₹750 Cr | ₹630 Cr |
What is the latest Net Current Assets ratio of TORRENT PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹905 Cr |
| Mar2024 | ₹186 Cr |
| Mar2023 | ₹-134 Cr |
| Mar2022 | ₹750 Cr |
| Mar2021 | ₹630 Cr |
How is Net Current Assets of TORRENT PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹905 Cr | 386.16 | |
| Mar2024 | ₹186 Cr | Positive | |
| Mar2023 | ₹-134 Cr | Negative | |
| Mar2022 | ₹750 Cr | 19.05 | |
| Mar2021 | ₹630 Cr | - | |
Compare Net Current Assets of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹138,121.3 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,402.0 Cr | 1.2% | -0.9% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,277.0 Cr | 2.7% | -3.8% | 5.9% | Stock Analytics | |
| CIPLA | ₹107,398.0 Cr | -0.1% | -8.2% | -8.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,378.0 Cr | 2.7% | 7.1% | 2.8% | Stock Analytics | |
| MANKIND PHARMA | ₹85,818.0 Cr | 0.9% | -6.1% | -15.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 2.1% |
2.8% |
30.9% |
| SENSEX | 0.4% |
-0.2% |
6.9% |
You may also like the below Video Courses